Governmental Non-Pharmaceutical Interventions during the COVID-19 Pandemic and the COPD Exacerbation and Respiratory Infection Rate in Patients with Alpha-1 Antitrypsin DeficiencyCOPD exacerbationscovid-19respiratory infectionsalpha-1 antitrypsin deficiency...
infection was performed. It has been documented that there was a significant correlation between comorbidities, including chronic respiratory disease, chronic cardiac disease, and morbid obesity with the disease severity and intensive care unit (ICU) admission [52]. Another cohort study of 7337 COVID-...
49.Phase Ib Controlled Exploratory Trial for Treatment of Fibrosing Interstitial Lung Disease Patients Secondary to SARS-CoV-2 Infection with IN01 Vaccine (COVINVAC);Identififier NCT04537130;Instituto Oncológico Dr Rosell:Barcelona,Spain,2020. 50....
Asthma or COPD exacerbation: History of reactive airway disease, wheezing , response to bronchodilators Allergic rhinitis : Seasonal pattern, itching, clear rhinorrhea , no fever Non-respiratory viral syndromes: EBV , CMV, HIV acute infection Vasculitis with pulmonary involvement : ANCA-associated ...
Vaccine Abbreviations ACE Angiotensin-converting enzyme AE Acute exacerbation AEC Alveolar epithelial cell Ang Angiotensin ARDS Acute respiratory distress syndrome COVID-19 Coronavirus disease 2019 CT Computed tomography CTD Connective tissue disease DAD Diffuse alveolar damage DLCO Diffusing capacity of the lu...
139 There is currently no data indicating that the effect of the vaccine is different in COPD patients than in the general population. Vascular pulmonary diseases The ability of SARS-CoV-2 to invade vascular endothelial cells leads to endothelial inflammation, thrombin generation, and platelet and ...
In addition, patients who had received even one dose of an mRNA vaccine against COVID-19 were also excluded. The medical records of a total of 450 patients with COVID-19 were analyzed retrospectively to determine the clinical factors associated with the severity of COVID-19 pneumonia. Clinical...
While scientists are striving to discover and produce safe and effective vaccines to halt the coronovirus outbreak, anti-vacciners are revving up misinformation campaigns.
Understanding the etiological bases of sexual dimorphism in COVID-19 could help develop more effective strategies in individual patients in both sexes, including designing a good vaccine. Similar content being viewed by others Sex hormones, autoimmunity and gender disparity in COVID-19 Article 26 ...
COVID-19 vaccines in patients with hypertension One of the fundamental progresses that have been made since the beginning of the current pandemic is the devel- opment of COVID-19 vaccines, which include mRNA vaccines (i.e., mRNA-1273 and BNT162b2), adenovirus vector vaccine (AZD1222), and...